Literature DB >> 3666354

Undertreatment of asthma in Dutch general practice.

A A Kaptein1, F W Dekker, K Gill, M A van der Waart.   

Abstract

The relationships between the medication prescribed and four measures of morbidity were assessed in 150 Dutch patients with asthma in general practice. Undertreatment was operationalized as a discrepancy between medication and morbidity severity. Of the patients, 11.3% were undertreated as measured by the number of days during which activities were interrupted by asthmatic symptoms. Additional measures such as the number of nights interrupted by asthma, number of attacks and episodes of wheezing, indicated that 28.0%, 24.0% and 34.5% of the patients respectively were undertreated. It is concluded that asthma seems to be undertreated in general practice in The Netherlands, a finding which is consistent with research on this subject in the UK and other countries. Possible reasons for the persistence of undertreatment of asthma are discussed, and suggestions for overcoming it are offered.

Entities:  

Mesh:

Year:  1987        PMID: 3666354     DOI: 10.1093/fampra/4.3.219

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  Impact of an interest in asthma on prescribing costs in general practice.

Authors:  K Jones
Journal:  Qual Health Care       Date:  1992-06

2.  Asthma--still a challenge for general practice.

Authors:  K Jones
Journal:  J R Coll Gen Pract       Date:  1989-06

3.  Knowledge of and reported asthma management among South Australian general practitioners.

Authors:  J R Coates; I D Steven; J Beilby; G Coffey; J C Litt; C Wagner
Journal:  Br J Gen Pract       Date:  1994-03       Impact factor: 5.386

4.  Predicting patient attitudes to asthma medication.

Authors:  L M Osman; I T Russell; J A Friend; J S Legge; J G Douglas
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

5.  Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

Authors:  F W Dekker; A C Schrier; P J Sterk; J H Dijkman
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.